J. Shifren

发表

Androgens, estrogens, and metabolic syndrome at midlife.

J. Shifren, 2009, Menopause.

Role of Hormone Therapy in the Management of Menopause

I. Schiff, J. Shifren, 2010, Obstetrics and gynecology.

Increased hot flash severity and related interference in perimenopausal human immunodeficiency virus–infected women

Sara E Looby, Alison M. Rope, S. Grinspoon, 2013, Menopause.

Endocrine aspects of women's sexual function.

N. Avis, S. Davis, R. Nappi, 2010, The journal of sexual medicine.

Efficacy of citalopram as a monotherapy or as an adjunctive treatment to estrogen therapy for perimenopausal and postmenopausal women with depression and vasomotor symptoms.

C. Soares, L. Cohen, J. Shifren, 2003, The Journal of clinical psychiatry.

In the human fetus, vascular endothelial growth factor is expressed in epithelial cells and myocytes, but not vascular endothelium: implications for mode of action.

N. Ferrara, S. Mesiano, R. Jaffe, 1994, The Journal of clinical endocrinology and metabolism.

A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes

N. Avis, R. Coeytaux, C. Legault, 2008, Menopause.

Female androgen insufficiency: the Princeton consensus statement on definition, classification, and assessment.

H. Burger, L. Dennerstein, G. Braunstein, 2002, Fertility and sterility.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society

K. Newton, N. Santoro, H. Hodis, 2015, Menopause.

Women's experience of vulvovaginal symptoms associated with menopause

R. Rosen, J. Simon, S. Kingsberg, 2019, Menopause.

Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study

L. Derogatis, S. Davis, C. Rodenberg, 2006, Menopause.

Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women: A Randomized, Placebo-Controlled Trial

N. Watts, G. Braunstein, J. Buster, 2005 .

Why the product labeling for low-dose vaginal estrogen should be changed

J. Manson, R. Rebar, R. Kagan, 2014, Menopause.

The National Academies of Science, Engineering, and Medicine (NASEM) Report on Compounded Bioidentical Hormone Therapy.

J. Manson, N. Santoro, S. Faubion, 2020, Menopause.

Sexual Function in Nondepressed Women Using Escitalopram for Vasomotor Symptoms: A Randomized Controlled Trial

S. Reed, E. Freeman, Rebecca A. Seguin, 2012, Obstetrics and gynecology.

Surgical menopause: effects on psychological well-being and sexuality

N. Avis, J. Shifren, 2007, Menopause.

Neuropsychological effects of methyltestosterone in women using menopausal hormone replacement.

Q. Regestein, I. Schiff, J. Shifren, 2001, Journal of women's health & gender-based medicine.

Effects of estradiol and venlafaxine on insomnia symptoms and sleep quality in women with hot flashes.

Julie L Otte, J. Manson, A. LaCroix, 2015, Sleep.

Sexual Arousal and Lubrication Problems in Women With Clinically Diagnosed Hypoactive Sexual Desire Disorder: Preliminary Findings from the Hypoactive Sexual Desire Disorder Registry for Women

R. Segraves, R. Rosen, Liyuan Huang, 2012, Journal of sex & marital therapy.

Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey

A. LaCroix, W. Utian, M. Gass, 2015, Menopause.

Angiogenesis and Macrophage Activation in Endometriosis

Robert N. Taylor, D. Hornung, J. Tseng, 1997, Annals of the New York Academy of Sciences.

Reproductive endocrine and endometrial effects of raloxifene hydrochloride, a selective estrogen receptor modulator, in women with regular menstrual cycles.

R. Jaffe, S. Allerheiligen, M. Draper, 1998, The Journal of clinical endocrinology and metabolism.

Angiogenesis in the human female reproductive tract.

R. Jaffe, J. Shifren, R. Taylor, 1995, Obstetrical & gynecological survey.

Healthcare utilization in women diagnosed with hypoactive sexual desire disorder: interim baseline results from the HSDD Registry for Women.

R. Rosen, E. Gerstenberger, Liyuan Huang, 2010, Journal of women's health.

Sexual frequency and pain in a randomized clinical trial of vaginal estradiol tablets, moisturizer, and placebo in postmenopausal women.

A. LaCroix, N. Woods, S. Reed, 2019, Menopause.

Knowledge and Needs of Resident Physicians Regarding Osteoporosis: A Nationwide Survey of Residents

D. Bauer, D. Elashoff, C. Crandall, 2021, JBMR plus.

Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women.

S. Siddhanti, J. Shifren, J. Pinkerton, 2003 .

Influence of raloxifene on the efficacy of an estradiol-releasing ring for treating vaginal atrophy in postmenopausal women

S. Siddhanti, J. Shifren, J. Pinkerton, 2003, Menopause.

Genitourinary Syndrome of Menopause.

J. Shifren, 2018, Clinical obstetrics and gynecology.

Increasing our understanding of women's sexuality at midlife and beyond.

J. Shifren, 2011, Menopause.

Response to a letter from Anderson et al

J. Manson, R. Karas, P. Schmidt, 2012 .

Menopausal Hormone Therapy.

J. Manson, C. Crandall, J. Shifren, 2019, JAMA.

Human fetal ovaries and uteri: developmental expression of genes encoding the insulin, insulin-like growth factor I, and insulin-like growth factor II receptors.

R. Osathanondh, J. Yeh, J. Shifren, 1993, Fertility and sterility.

Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.

L. Derogatis, C. Rodenberg, S. Kingsberg, 2007, The journal of sexual medicine.

Absence of polycystic ovary syndrome features in human immunodeficiency virus-infected women despite significant hyperinsulinemia and truncal adiposity.

S. Grinspoon, J. Shifren, S. Johnsen, 2005, The Journal of clinical endocrinology and metabolism.

Associations of hypertensive disorders of pregnancy and gestational diabetes mellitus with menopausal symptoms at midlife in Project Viva

S. Rifas-Shiman, M. Hivert, E. Oken, 2022, Menopause.

The aging ovary.

I. Schiff, J. Shifren, Isaac Schiff, 2000, Journal of women's health & gender-based medicine.

Longitudinal associations of psychosocial stressors with menopausal symptoms and well-being among women in midlife

H. Tiemeier, S. Rifas-Shiman, M. Hivert, 2022, Menopause.

Self-reported menstrual cycle length during reproductive years in relation to menopausal symptoms at midlife in Project Viva

S. Rifas-Shiman, M. Hivert, E. Oken, 2022, Menopause.

The relationship between human semen characteristics and sperm apoptosis: a pilot study.

R. Hauser, Narendra Singh, Zuying Chen, 2006, Journal of andrology.

Transdermal Testosterone for Women:: A New Physiological Approach for Androgen Therapy

N. Mazer, J. Shifren, 2003, Obstetrical & gynecological survey.

NAMS supports judicious use of systemic hormone therapy for women aged 65 years and older.

P. Maki, P. Schnatz, M. Gass, 2015, Menopause.

Correlates of sexually related personal distress in women with low sexual desire.

C. Johannes, B. Monz, R. Rosen, 2009, The journal of sexual medicine.

Sexual desire problems in women seeking healthcare: a novel study design for ascertaining prevalence of hypoactive sexual desire disorder in clinic-based samples of U.S. women.

L. Derogatis, W. Fisher, R. Rosen, 2012, Journal of women's health.

Endocrine aspects of female sexual dysfunction.

S. Davis, N. Mazer, A. Guay, 2004, The journal of sexual medicine.

Sexual Function in Women on Estradiol or Venlafaxine for Hot Flushes: A Randomized Controlled Trial

J. Manson, A. LaCroix, K. Newton, 2014, Obstetrics and gynecology.

Self-reported sleep in postmenopausal women

Q. Regestein, I. Schiff, M. Scharf, 2004, Menopause.

Mind–body group treatment for women coping with infertility: a pilot study

E. Park, J. Denninger, A. K. Styer, 2015, Journal of psychosomatic obstetrics and gynaecology.

Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis

K. Newton, S. Reed, E. Freeman, 2016, Archives of Sexual Behavior.

Sexual Problems and Distress in United States Women: Prevalence and Correlates

C. Johannes, B. Monz, Anthony Segreti, 2008, Obstetrics and gynecology.

CLINICAL ASSISTED REPRODUCTION: Antral Follicle Assessment as a Tool for Predicting Outcome in IVF—Is it a Better Predictor than Age and FSH?

T. Toth, Yuchiao Chang, R. Nahum, 2004, Journal of Assisted Reproduction and Genetics.

The 2017 hormone therapy position statement of The North American Menopause Society

J. Manson, L. Nelson, H. Hodis, 2017, Menopause.

Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis.

Y. Meng, N. Ferrara, J. Tseng, 1996, The Journal of clinical endocrinology and metabolism.

A randomized, open-label, crossover study comparing the effects of oral versus transdermal estrogen therapy on serum androgens, thyroid hormones, and adrenal hormones in naturally menopausal women

G. Doros, N. Mazer, S. Desindes, 2007, Menopause.

Ovarian steroid and cytokine modulation of human endometrial angiogenesis.

M. Mueller, P. Darney, I. Ryan, 2000, Human reproduction.

The North American Menopause Society recommendations for clinical care of midlife women.

M. Gass, J. Shifren, 2014, Menopause.

REPRODUCTIVE ENDOCRINE AND ENDOMETRIAL EFFECTS OF RALOXIFENE HYDROCHLORIDE, A SELECTIVE ESTROGEN RECEPTOR MODULATOR, IN WOMEN WITH REGULAR MENSTRUAL C YCLES

R. Jaffe, S. Allerheiligen, M. Draper, 1998 .

Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax.

John Calvin Reed, S. Krajewski, J. Tilly, 1997, The Journal of clinical endocrinology and metabolism.

SERMs in postmenopausal Women’s health

L. Plouffe, J. Shifren, 2002 .

Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells.

D. Hornung, J. Vigne, J. Shifren, 1998, Fertility and sterility.

P-1 . The Vulvovaginal Atrophy Questionnaire ( VVAQ ) : A Novel Patient-Reported Outcome ( PRO ) for Assessing Symptoms of Vulvovaginal Atrophy in Menopausal Women

R. Rosen, J. Simon, S. Kingsberg, 2017 .

Impact of Varying Stages of Endometriosis on the Outcome of In Vitro Fertilization–Embryo Transfer

T. Toth, Yuchiao Chang, K. Isaacson, 2004, Journal of Assisted Reproduction and Genetics.

Toward a better measure of midlife sexual function: pooled analyses in nearly 1,000 women participating in MsFLASH randomized trials

A. LaCroix, N. Woods, S. Reed, 2022, Menopause.

Erratum: Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study (Menopause (2006) 13, (770-779))

S. Davis, J. Shifren, M. Moreau, 2007 .

Help-seeking behavior of women with self-reported distressing sexual problems.

C. Johannes, B. Monz, R. Rosen, 2009, Journal of women's health.

The role of androgens in female sexual dysfunction.

J. Shifren, 2004, Mayo Clinic proceedings.

Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.

N. Watts, G. Braunstein, J. Buster, 2006, Archives of internal medicine.

Distressing sexual problems in United States women revisited: prevalence after accounting for depression.

C. Johannes, B. Monz, R. Rosen, 2009, The Journal of clinical psychiatry.

Androgens in postmenopausal women: a review

S. Davis, J. Shifren, 2017, Menopause.

Androgen deficiency in the oophorectomized woman.

J. Shifren, 2002, Fertility and sterility.

Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells.

N. Ferrara, S. Mesiano, R. Jaffe, 1998, The Journal of clinical endocrinology and metabolism.

Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study

J. Manson, J. Cauley, R. Chlebowski, 2017, Menopause.

Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society

J. Manson, S. Silverman, V. Henderson, 2006, Menopause.

A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women.

N. Rifai, G. Doros, N. Mazer, 2008, The Journal of clinical endocrinology and metabolism.

Nams Continuing Medical Education Activity

L. Dennerstein, S. Davis, J. Heiman, 2022 .

Vaginal estrogen use and chronic disease risk in the Nurses' Health Study.

J. Manson, W. Willett, F. Grodstein, 2019, Menopause.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.

J. Manson, A. LaCroix, K. Rexrode, 2014, JAMA internal medicine.

Effect of a baseline ovarian cyst on the outcome of in vitro fertilization-embryo transfer.

T. Toth, K. Isaacson, L. Pal, 1999, Fertility and sterility.

Safety and Efficacy of a Testosterone Patch for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women

N. Watts, G. Braunstein, J. Buster, 2005 .

The presentation of hypoactive sexual desire disorder in premenopausal women.

G. Braunstein, R. Rosen, E. Gerstenberger, 2010, The journal of sexual medicine.

Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding.

Robert N. Taylor, C. Zaloudek, P. Darney, 2005, The Journal of clinical endocrinology and metabolism.

Outcome of IVF in DES-Exposed Daughters: Experience in the 90s

T. Toth, Yuchiao Chang, K. Isaacson, 1997, Journal of Assisted Reproduction and Genetics.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial

J. Manson, A. LaCroix, B. Sternfeld, 2015, Menopause.

Association between HIV status and psychological symptoms in perimenopausal women

Sara E Looby, S. Grinspoon, L. Smeaton, 2018, Menopause.

Rethinking Menopausal Hormone Therapy: For Whom, What, When, and How Long?

K. Lindley, L. Cho, S. Hayes, 2023, Circulation.

Testosterone for midlife women: the hormone of desire?

J. Shifren, 2015, Menopause.

Transdermal Testosterone Treatment in Women With Impaired Sexual Function After Oophorectomy

G. Braunstein, R. Rosen, S. Leiblum, 2001 .

Short-term use of estradiol for depression in perimenopausal and postmenopausal women: a preliminary report.

C. Soares, L. Cohen, J. Shifren, 2003, The American journal of psychiatry.

Is testosterone or estradiol the hormone of desire? A novel study of the effects of testosterone treatment and aromatase inhibition in postmenopausal women.

J. Shifren, 2006, Menopause.

A core outcome set for vasomotor symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

L. Kiesel, S. Iliodromiti, M. Hickey, 2021, Menopause.

Medical therapy for female sexual dysfunction

J. Shifren, A. Mark, 2003 .

Female Sexual Function Index Short Version: A MsFLASH Item Response Analysis

K. Newton, S. Reed, E. Freeman, 2016, Archives of sexual behavior.

Is there a role for testosterone therapy in premenopausal women?

J. Shifren, 2003, Menopause.

Mid-40s menopause transition: not premature, but associated with sexual dysfunction.

J. Shifren, 2022, Menopause.

Improving the identification of genitourinary syndrome of menopause through the utilization of the Day-to-Day Impact of Vaginal Aging questionnaire.

J. Thompson, A. Zuckerman, Katherine Pereira, 2020, Menopause.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society

Hadine Joffe, JoAnn E Manson, Marla Shapiro, 2015, Menopause.

Using an FSDS-R Item to Screen for Sexually Related Distress: A MsFLASH Analysis

K. Newton, S. Reed, J. Carpenter, 2014, Sexual medicine.

Menopause, Me and You???The Sound of Women Pausing

R. Nahum, J. Shifren, 1998 .

Hormone therapy and midlife sexuality-is estrogen a hormone of desire?

J. Shifren, 2023, Menopause.

A Comparison of the Short-Term Effects of Oral Conjugated Equine Estrogens Versus Transdermal Estradiol on C-Reactive Protein, Other Serum Markers of Inflammation, and Other Hepatic Proteins in Naturally Menopausal Women

N. Rifai, G. Doros, N. Mazer, 2008 .

Preliminary observations on differing psychological effects of conjugated and esterified estrogen treatments.

Q. Regestein, I. Schiff, J. Shifren, 2001, Journal of women's health & gender-based medicine.

A core outcome set for genitourinary symptoms associated with menopause: the COMMA (Core Outcomes in Menopause) global initiative

L. Kiesel, S. Iliodromiti, C. Niederberger, 2021, Menopause.

Exploring the relationship between history of infertility and the experience of menopausal symptoms

S. Rifas-Shiman, E. Oken, J. Chavarro, 2023, Menopause.

Need for Migraine/Perimenopausal Research

N. Maleki, C. Bernstein, J. Shifren, 2018, Headache.

Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial

N. Watts, G. Braunstein, S. Davis, 2006, Menopause.

Transdermal testosterone treatment in women with impaired sexual function after oophorectomy.

Orman, G. Braunstein, Imon, 2000, The New England journal of medicine.

Effects of estrogen and venlafaxine on menopause-related quality of life in healthy postmenopausal women with hot flashes: a placebo-controlled randomized trial

J. Manson, A. LaCroix, B. Sternfeld, 2015, Menopause.

Low-dose estradiol and the serotonin-norepinephrine reuptake inhibitor venlafaxine for vasomotor symptoms: a randomized clinical trial.

J. Manson, A. LaCroix, K. Rexrode, 2014, JAMA internal medicine.

NAMS continuing medical education activity Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society

J. Manson, D. Kendler, C. Stuenkel, 2010 .

Midlife sexuality in women's words.

J. Shifren, 2019, Menopause.

Nonhormonal management of menopause-associated vasomotor symptoms: 2015 position statement of The North American Menopause Society

K. Newton, N. Santoro, H. Hodis, 2015, Menopause.

A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes

N. Avis, R. Coeytaux, C. Legault, 2008, Menopause.

Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey

A. LaCroix, W. Utian, M. Gass, 2015, Menopause.

S. Iliodromiti, U. Jaisamrarn, K. Giblin, 2024, Menopause.

Correlates of sexually related personal distress in women with low sexual desire.

B. Monz, Patricia A. Russo, J. Shifren, 2009, The journal of sexual medicine.

Incidence of sexual dysfunction in surgically menopausal women.

R. Nahum, N. Mazer, J. Shifren, 1998, Menopause.